Understanding the Basic Requirement of the Bacterial Endotoxin Testing (BET) or LAL Program

This webinar will help the attendee gain an understanding of the requirements of current USP <85> Bacterial Endotoxin Test (BET), European Pharmacopoeia (Chapter 2.6.14) and the Japanese Pharmacopoeia (General Tests, No. 4.01). The webinar will provide the attendee the ability to understand the different LAL testing methodologies, choosing the best test method applicable to the product type, criticality of the BET test result as it applies to the release of a cGMP manufactured product. 

Who Will Benefit:

This topic applies to personnel/companies in the Pharmaceutical, Biotechnology and Medical Device Industries. The employees who will benefit most include:

• Quality Control Analyst and Management
• Senior Management
• Manufacturing Associates and Management
• Quality Assurance Analyst and Management

Instructor Profile: 

Charity Ogunsanya (CEO/Founder, Pharmabiodevice Consulting LLC) has over 23 years of extensive experience within the pharmaceutical, biotechnology, biologics, cell-therapy, diagnostics, research and development, radio-pharmaceutical, contract manufacturing organizations (CMOs) and medical device companies. 

Note:

Use coupon code NB5SQH8N and get 10% off on registration.

For Registration:

http://www.complianceonline.com/understanding-the-basic-requirement-of-the-bacterial-endotoxin-testing-program-webinar-training-705008-prdw?channel=sciencedz